HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 20, 16:00
HemoGenyx Pharmaceuticals Gross Profit (TTM) : -0.6994M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6994M |
| December 31, 2025 | -0.7751M |
| June 30, 2025 | -0.8168M |
| December 31, 2024 | -0.8168M |
| June 30, 2024 | -0.8151M |
| December 31, 2023 | -0.8027M |
| June 30, 2023 | -1.019M |
| December 31, 2022 | -0.6663M |
| June 30, 2022 | -0.1292M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.1738M |
| June 30, 2021 | -0.1623M |
| December 31, 2020 | -0.1371M |
| June 30, 2020 | -0.1457M |
| December 31, 2019 | -0.1202M |
| June 30, 2019 | -0.0707M |
| December 31, 2018 | -0.0691M |
| June 30, 2018 | -0.034M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Silence Therapeutics Plc | 0.0975M |
| Biodexa Pharmaceuticals Plc | -0.1719M |
| NuCana Plc | -0.3717M |
| Mereo BioPharma Group Plc | -1.195M |
| Compass Pathways Plc | -0.0209M |